Australian Medical Research and Innovation Priorities 2022–2024
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Following a national consultation, the priorities were developed by the Australian Medical Research Advisory Board (AMRAB) and must be considered by Government when making decisions about funding from the MRFF.
AMRAB has developed these priorities concurrently with the Australian Medical Research and Innovation Strategy 2021-2026 to align with and facilitate the achievement of the Strategy’s vision, aim and strategic objectives. These priorities took effect on 6 November 2022, superseding the Australian Medical Research and Innovation Priorities 2020-2022, which were in force until 5 November 2022.
The current MRFF priorities are:
- consumer-driven research
- research infrastructure and capability
- translation and commercialisation
- comparative effectiveness research
- preventive and public health research
- primary care research
- health and medical researcher capacity and capability
- Aboriginal and Torres Strait Islander health
- priority populations
- antimicrobial resistance
- global health and health security
- health impacts from environmental factors
- data, digital health and artificial intelligence.